Literature DB >> 19602909

A dynamic technique for the treatment of severe or recurrent blepharoptosis: frontalis-orbicularis oculi muscle flap shortening.

Chung-Sheng Lai1, Kao-Ping Chang, Ching Hung Lai, Shu-Hung Huang, Chih-Cheng Tsai, Sin-Daw Lin.   

Abstract

BACKGROUND: Severe or recurrent blepharoptosis remains a great challenge to most plastic surgeons. A variety of techniques have been developed according to the function of the levator palpebrae superioris and frontalis muscles. In this study, the frontalis-orbicularis oculi (FOO) muscle flap is designed as an entity to treat severe or recurrent blepharoptosis with satisfactory results.
METHODS: Between January 1997 and July 2007, FOO muscle flap shortening was applied to correct severe or recurrent blepharoptosis in 29 patients (38 eyelids), aged from 3 to 77 years. There were 11 males and 18 females, with bilateral ptosis in 9 patients. The follow-up period ranged from 10 to 52 months.
RESULTS: Twenty-four patients (82%) had good results, with the degree of ptosis less than 2 mm. The remaining 5 patients had fair results, and received readjustment in 2 cases.
CONCLUSION: In our study, fresh cadaver dissection revealed that the frontalis muscle is connected and interdigitated very closely with the orbicularis oculi muscle. Based on the anatomic study and literature review, we suggest that the FOO muscle flap shortening is a good alternative to treat severe or recurrent blepharoptosis. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19602909     DOI: 10.1159/000228589

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  3 in total

1.  The Function-Preserving Frontalis Orbicularis Oculi Muscle Flap for the Correction of Severe Blepharoptosis With Poor Levator Function.

Authors:  Shu-Hung Huang; Chia-Chen Lee; Hsin-Ti Lai; Hidenobu Takahashi; Yu-Chi Wang; Chung-Sheng Lai
Journal:  Aesthet Surg J       Date:  2021-05-18       Impact factor: 4.283

2.  Frontalis Suspension in Muscular Dystrophy: 16-years Follow-up.

Authors:  Badr M I Abdulrauf
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-03-22

3.  Case Report: Botulinum Toxin-A for Complication of Exposure Keratopathy Following Frontalis-Orbicularis Oculi Muscle Flap Shortening.

Authors:  Chun-Chieh Lai; Chia-Chen Lin
Journal:  Front Med (Lausanne)       Date:  2022-04-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.